Home » Topics » Regulatory

Regulatory
RSS

Transmucosal clemastine under study at Nastech for motion sickness

Feb. 16, 2000

Bio-Technology General obtains first marketing approval worldwide for HBV vaccine

Feb. 15, 2000

Ophthalmic antibacterial on the way to market in Japan

Feb. 15, 2000

FDA approves Actimmune for treatment of osteopetrosis

Feb. 14, 2000

Preclinical studies support potential new indication for tamsulosin

Feb. 14, 2000

Nastech claims formulations of sildenafil for nasal delivery

Feb. 11, 2000

Improved topical formulations of aciclovir developed at Recordati

Feb. 11, 2000

FDA approves Lotronex for IBS in women

Feb. 10, 2000

Potential new use for imiquimod explored in small clinical study

Feb. 10, 2000

Insulin sensitizer-anorectic combinations disclosed by Takeda for NIDDM

Feb. 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...